関節痛注射の世界市場レポート 2025年

関節痛注射の市場規模は今後数年で急成長が見込まれます。2029年にはCAGR12.3％で98億1,000万米ドルに成長します。予測期間の成長は、遠隔医療サービスの拡大、個別化された疼痛管理、患者教育とエンパワーメント、持続可能なヘルスケア実践、栄養サポートに起因すると考えられます。予測期間の主な動向には、再生医療、個別化疼痛管理、革新的注射材料、リハビリテーション技術、人工知能AI強化注射などがあります。

関節炎と筋骨格系障害の有病率の増加が関節痛注射市場の成長を促進すると予想されます。筋骨格系障害は世界的に障害の主な原因であり、腰痛は160カ国で障害の最も一般的な原因として特定されています。疼痛患者は、疼痛緩和や炎症状態の管理のために注射を受けることが多いです。例えば、2023年6月、オーストラリアの政府機関であるAustralian Institute of Health and Welfareは、関節リウマチが全疾患負担の2.0％、筋骨格系疾患に関連する全疾患負担の16％を占めると報告しました。2022年には1,322人が死亡し、これは人口10万人当たり5.1人の死亡に相当し、全死亡の0.7％を占めました。したがって、関節炎と筋骨格系疾患の有病率の上昇が関節痛注射市場を牽引しています。

慢性疼痛の罹患率の上昇は、関節痛注射市場の今後の成長を促進すると予測されています。慢性疼痛は、長期間続く持続的または長期的な不快感を特徴とし、一般的には少なくとも3～6ヶ月、または予想される治癒期間を超えて持続すると定義されます。関節痛注射は、慢性疼痛、特に変形性関節症、関節リウマチ、その他の関節関連疾患などの筋骨格系疾患に関連する慢性疼痛の管理に一般的に利用されています。例えば、2022年9月、世界保健機関（WHO）は2022年ハイライトの中で、非感染性疾患（NCDs）または慢性疾患による死亡者数は4,100万人で、世界全体の死亡者数の74％を占めると報告しました。その結果、慢性疼痛の発生率の増加が関節痛注射市場の成長を促進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界成長分析と戦略分析フレームワーク

• 世界の関節痛注射PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の関節痛注射市場成長率分析
• 世界の関節痛注射市場の実績：規模と成長, 2019-2024
• 世界の関節痛注射市場の予測：規模と成長, 2024-2029, 2034F
• 世界の関節痛注射総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の関節痛注射市場：注射タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ステロイド関節注射
• ヒアルロン酸注射
• 多血小板血漿（PRP）注射
• 胎盤組織マトリックス（PTM）注射
• その他のタイプの注射
• 世界の関節痛注射市場：関節タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 股関節
• 膝と足首
• 肩と肘
• 脊椎の椎間関節
• その他の関節タイプ
• 世界の関節痛注射市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界の関節痛注射市場：ステロイド関節注射のサブセグメンテーション、注射タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• コルチコステロイド注射
• 複合ステロイド注射
• 世界の関節痛注射市場：ヒアルロン酸注射のサブセグメンテーション、注射タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 単回投与ヒアルロン酸注射
• 複数回ヒアルロン酸注射
• 世界の関節痛注射市場：多血小板血漿（PRP）注射のサブセグメンテーション、注射タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自己PRP注射
• 同種PRP注射
• 世界の関節痛注射市場：胎盤組織マトリックス（PTM）注射のサブセグメンテーション、注射タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 羊水注射
• 胎盤由来細胞注射
• 世界の関節痛注射市場：その他のタイプの注射のサブセグメンテーション、注射タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 骨髄吸引濃縮液（BMAC）注射
• 幹細胞注射
• 遺伝子組み換え細胞注射

第7章 地域別・国別分析

• 世界の関節痛注射市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の関節痛注射市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 関節痛注射市場：競合情勢
• 関節痛注射市場：企業プロファイル
  • Seikagaku Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Flexion Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Anika Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Abbvie Inc.
• Bioventus Inc.
• Eli Lilly and Company
• Ferring Pharmaceuticals Inc.
• Pfizer Inc.
• Teva Pharmaceutical Industries Limited
• Johnson & Johnson Services Ltd.
• Merck & Co. Inc.
• GlaxoSmithKline plc
• Novartis AG
• AstraZeneca plc
• Roche Holding AG
• Bristol-Myers Squibb Company
• Boehringer Ingelheim International GmbH
• Takeda Pharmaceutical Company Limited

第32章 世界市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 市場の最近の動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 関節痛注射市場2029年-最も新しい機会を提供する国
• 関節痛注射市場2029年-最も新しい機会を提供するセグメント
• 関節痛注射市場2029年-成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Joint pain injections serve to reduce inflammation and discomfort, typically administered directly into the joint to alleviate pain. Joint pain is a common occurrence, particularly among the elderly or individuals with pre-existing medical conditions or disorders. Conditions such as arthritis, characterized by pain and inflammation, often contribute to joint pain. Joint pain injections offer a non-surgical approach to quickly relieve joint pain and inflammation.

The primary types of injections for joint pain include steroid joint injections, hyaluronic acid injections, platelet-rich plasma (PRP) injections, placental tissue matrix (PTM) injections, and various others. Steroid joint injections, also known as corticosteroid injections, are anti-inflammatory medications used to treat joint pain. They are particularly effective in reducing inflammation in individuals with conditions like rheumatoid arthritis and other forms of inflammatory arthritis. Joint pain injections are applied to various types of joints, including the hip joint, knee and ankle joints, shoulder and elbow joints, facet joints of the spine, and others. These injections are commonly distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

The joint pain injections market research report is one of a series of new reports from The Business Research Company that provides joint pain injections market statistics, including joint pain injections industry global market size, regional shares, competitors with a joint pain injections market share, detailed joint pain injections market segments, market trends and opportunities, and any further data you may need to thrive in the joint pain injections industry. This joint pain injections market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The joint pain injections market size has grown rapidly in recent years. It will grow from $5.6 billion in 2024 to $6.17 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to increased aging population, arthritis prevalence, global health initiatives, healthcare digitalization, increasing awareness of chronic pain management.

The joint pain injections market size is expected to see rapid growth in the next few years. It will grow to $9.81 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to expansion of telehealth services, personalized pain management, patient education and empowerment, sustainable healthcare practices, nutritional support. Major trends in the forecast period include regenerative medicine, personalized pain management, innovative injection materials, rehabilitation technologies, artificial intelligence ai-enhanced injections.

The increasing prevalence of arthritis and musculoskeletal disorders is expected to drive the growth of the joint pain injections market. Musculoskeletal disorders are the leading cause of disability globally, with low back pain identified as the most common cause of impairment in 160 countries. Patients often seek injections for pain relief and to manage inflammatory conditions. For example, in June 2023, the Australian Institute of Health and Welfare, a government agency in Australia, reported that rheumatoid arthritis accounted for 2.0% of the total disease burden and 16% of the overall burden of disease related to musculoskeletal conditions. In 2022, it resulted in 1,322 deaths, equating to 5.1 deaths per 100,000 people, which represented 0.7% of all deaths. Therefore, the rising prevalence of arthritis and musculoskeletal disorders is driving the joint pain injections market.

The rising incidence of chronic pain is anticipated to drive the growth of the joint pain injections market in the future. Chronic pain is characterized by persistent or long-lasting discomfort that continues for an extended duration, typically defined as lasting at least three to six months or beyond the expected healing time. Joint pain injections are commonly utilized to manage chronic pain, particularly when it is linked to musculoskeletal conditions such as osteoarthritis, rheumatoid arthritis, or other joint-related issues. For example, in September 2022, the World Health Organization (WHO) reported in its 2022 Highlights that there were 41 million deaths, accounting for 74% of all fatalities due to noncommunicable diseases (NCDs) or chronic diseases globally each year. Consequently, the increase in the incidence of chronic pain is propelling the growth of the joint pain injections market.

A prominent trend in the joint pain injections market is the focus on new product development. Major companies in this sector are actively engaged in innovating new products to meet consumer demand and enhance their market position. For instance, Contura International Ltd., a UK-based manufacturer of therapeutic hydrogels, introduced Arthrosamid in September 2021. Arthrosamid, an innovative hydrogel injection for knee osteoarthritis, utilizes non-biodegradable hydrogel technology, providing a potent, long-lasting, secure, and minimally intrusive treatment for knee osteoarthritis pain.

Leading companies in the joint pain injections market are concentrating on developing innovations such as single-injection formulations, which prioritize patient convenience. A single-injection formulation is a type of drug delivery system designed to deliver a specific dose of medication in a single injection, offering sustained therapeutic effects over an extended period without the need for multiple doses. For example, in July 2024, LG Chem Ltd., a chemicals company based in South Korea, introduced Synovian, a new treatment for knee osteoarthritis in China that features a convenient single-injection formulation, making it the first of its kind in the country. The product aims to capture a significant market estimated at around KRW 200 billion (approximately USD 150 million). Developed using proprietary technology, it demonstrates innovation in meeting patient needs, focusing on providing effective relief with minimal administration effort.

In November 2022, Biocon Biologics Limited, a pharmaceutical company based in India, acquired the biosimilars business from Viatris Inc. for $3.33 billion. This acquisition enables Biocon to utilize Viatris' extensive experience and established presence in the global market, improving access to critical therapies for patients around the world. This strategic move is anticipated to enhance its biosimilars portfolio, including Adalimumab BS for subcutaneous injection, which is indicated for immune-related diseases like rheumatoid arthritis. Viatris Inc. is a healthcare company based in the US that offers joint pain medications.

Major companies operating in the joint pain injections market include Seikagaku Corporation, Flexion Therapeutics Inc., Zimmer Biomet Holdings Inc., Sanofi S.A., Anika Therapeutics Inc., Abbvie Inc., Bioventus Inc., Eli Lilly and Company, Ferring Pharmaceuticals Inc., Pfizer Inc., Teva Pharmaceutical Industries Limited, Johnson & Johnson Services Ltd., Merck & Co. Inc., GlaxoSmithKline plc, Novartis AG, AstraZeneca plc, Roche Holding AG, Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Takeda Pharmaceutical Company Limited, Bayer AG, Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Ipsen SA, Mallinckrodt Pharmaceuticals Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., Zydus Lifesciences Limited

North America was the largest region in the joint pain injections market in 2024. The regions covered in the joint pain injections market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the joint pain injections market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The joint pain injections market consists of sales of epidural steroid injections, facet joint injections, viscosupplementation injections, corticosteroid injections and hyaluronic acid injections. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Joint Pain Injections Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on joint pain injections market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for joint pain injections ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The joint pain injections market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type Of Injection: Steroid Joint Injection; Hyaluronic Acid Injections; Platelet-Rich Plasma (PRP) Injections; Placental Tissue Matrix (PTM) Injections; Other Type Of Injections
• 2) By Joint Type: Hip Joint; Knee And Ankle; Shoulder And Elbow; Facet Joints Of The Spine; Other Joint Types
• 3) By Distribution channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Steroid Joint Injection: Corticosteroid Injections; Combination Steroid Injections
• 2) By Hyaluronic Acid Injections: Single-Dose Hyaluronic Acid Injections; Multi-Dose Hyaluronic Acid Injections
• 3) By Platelet-Rich Plasma (PRP) Injections: Autologous PRP Injections; Allogeneic PRP Injections
• 4) By Placental Tissue Matrix (PTM) Injections: Amniotic Fluid Injections; Placental Derived Cell Injections
• 5) By Other Types of Injections: Bone Marrow Aspirate Concentrate (BMAC) Injections; Stem Cell Injections; Genetically Engineered Cell Injections
• Companies Mentioned: Seikagaku Corporation; Flexion Therapeutics Inc.; Zimmer Biomet Holdings Inc.; Sanofi S.A.; Anika Therapeutics Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Joint Pain Injections Market Characteristics

3. Joint Pain Injections Market Trends And Strategies

4. Joint Pain Injections Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Joint Pain Injections Growth Analysis And Strategic Analysis Framework

• 5.1. Global Joint Pain Injections PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Joint Pain Injections Market Growth Rate Analysis
• 5.4. Global Joint Pain Injections Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Joint Pain Injections Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Joint Pain Injections Total Addressable Market (TAM)

6. Joint Pain Injections Market Segmentation

• 6.1. Global Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Steroid Joint Injection
• Hyaluronic Acid Injections
• Platelet-Rich Plasma (PRP) Injections
• Placental Tissue Matrix (PTM) Injections
• Other Type Of Injection
• 6.2. Global Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hip Joint
• Knee And Ankle
• Shoulder And Elbow
• Facet Joints Of The Spine
• Other Joint Types
• 6.3. Global Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.4. Global Joint Pain Injections Market, Sub-Segmentation Of Steroid Joint Injection, By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroid Injections
• Combination Steroid Injections
• 6.5. Global Joint Pain Injections Market, Sub-Segmentation Of Hyaluronic Acid Injections, By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Dose Hyaluronic Acid Injections
• Multi-Dose Hyaluronic Acid Injections
• 6.6. Global Joint Pain Injections Market, Sub-Segmentation Of Platelet-Rich Plasma (PRP) Injections, By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Autologous PRP Injections
• Allogeneic PRP Injections
• 6.7. Global Joint Pain Injections Market, Sub-Segmentation Of Placental Tissue Matrix (PTM) Injections, By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Amniotic Fluid Injections
• Placental Derived Cell Injections
• 6.8. Global Joint Pain Injections Market, Sub-Segmentation Of Other Types of Injections, By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bone Marrow Aspirate Concentrate (BMAC) Injections
• Stem Cell Injections
• Genetically Engineered Cell Injections

7. Joint Pain Injections Market Regional And Country Analysis

• 7.1. Global Joint Pain Injections Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Joint Pain Injections Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Joint Pain Injections Market

• 8.1. Asia-Pacific Joint Pain Injections Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Joint Pain Injections Market

• 9.1. China Joint Pain Injections Market Overview
• 9.2. China Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Joint Pain Injections Market

• 10.1. India Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Joint Pain Injections Market

• 11.1. Japan Joint Pain Injections Market Overview
• 11.2. Japan Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Joint Pain Injections Market

• 12.1. Australia Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Joint Pain Injections Market

• 13.1. Indonesia Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Joint Pain Injections Market

• 14.1. South Korea Joint Pain Injections Market Overview
• 14.2. South Korea Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Joint Pain Injections Market

• 15.1. Western Europe Joint Pain Injections Market Overview
• 15.2. Western Europe Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Joint Pain Injections Market

• 16.1. UK Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Joint Pain Injections Market

• 17.1. Germany Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Joint Pain Injections Market

• 18.1. France Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Joint Pain Injections Market

• 19.1. Italy Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Joint Pain Injections Market

• 20.1. Spain Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Joint Pain Injections Market

• 21.1. Eastern Europe Joint Pain Injections Market Overview
• 21.2. Eastern Europe Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Joint Pain Injections Market

• 22.1. Russia Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Joint Pain Injections Market

• 23.1. North America Joint Pain Injections Market Overview
• 23.2. North America Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Joint Pain Injections Market

• 24.1. USA Joint Pain Injections Market Overview
• 24.2. USA Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Joint Pain Injections Market

• 25.1. Canada Joint Pain Injections Market Overview
• 25.2. Canada Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Joint Pain Injections Market

• 26.1. South America Joint Pain Injections Market Overview
• 26.2. South America Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Joint Pain Injections Market

• 27.1. Brazil Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Joint Pain Injections Market

• 28.1. Middle East Joint Pain Injections Market Overview
• 28.2. Middle East Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Joint Pain Injections Market

• 29.1. Africa Joint Pain Injections Market Overview
• 29.2. Africa Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Joint Pain Injections Market Competitive Landscape And Company Profiles

• 30.1. Joint Pain Injections Market Competitive Landscape
• 30.2. Joint Pain Injections Market Company Profiles
  • 30.2.1. Seikagaku Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Flexion Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Anika Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Joint Pain Injections Market Other Major And Innovative Companies

• 31.1. Abbvie Inc.
• 31.2. Bioventus Inc.
• 31.3. Eli Lilly and Company
• 31.4. Ferring Pharmaceuticals Inc.
• 31.5. Pfizer Inc.
• 31.6. Teva Pharmaceutical Industries Limited
• 31.7. Johnson & Johnson Services Ltd.
• 31.8. Merck & Co. Inc.
• 31.9. GlaxoSmithKline plc
• 31.10. Novartis AG
• 31.11. AstraZeneca plc
• 31.12. Roche Holding AG
• 31.13. Bristol-Myers Squibb Company
• 31.14. Boehringer Ingelheim International GmbH
• 31.15. Takeda Pharmaceutical Company Limited

32. Global Joint Pain Injections Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Joint Pain Injections Market

34. Recent Developments In The Joint Pain Injections Market

35. Joint Pain Injections Market High Potential Countries, Segments and Strategies

• 35.1 Joint Pain Injections Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Joint Pain Injections Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Joint Pain Injections Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer